LLY
Eli Lilly and Company
$1,178.58
▲ +0.80%
+$9.41
NYSE · Healthcare · Drug Manufacturers - General
Eli Lilly and Company
LLY · NYSE · Healthcare · Drug Manufacturers - General
$1,178.58
▲ +0.80% · +$9.41 today
fundamentals76.3 /100 vs peers · 100% coverage
strong
5 of 5 metrics · 100% coverage
Revenue growth (TTM)47.4
237% above Sector 5Y avg avg · favorableSector 5Y avg: 14.1
EPS growth (TTM)130.0
1024% above Sector 5Y avg avg · favorableSector 5Y avg: 11.6
EPS forecast (5Y)28.5
98% above Sector fwd avg avg · favorableSector fwd avg: 14.4
EPS next year21.8
strong pace
EPS growth (Q/Q)169.4
strong pace
Missing inputs are treated as neutral uncertainty; compared with sector peers where available.
vs sector peers
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| LLYEli Lilly and Company | $1.05T | 41.8 | +47.4% | 76 |
| GMEDGlobus Medical | $10.60B | 18.2 | +23.5% | 78 |
| INDVIndivior | $4.94B | 20.5 | +10.3% | 78 |
| DXCMDexcom | $28.93B | 32.1 | +16.1% | 77 |
| BSXBoston Scientific Corporation | $66.54B | 18.8 | +17.4% | 73 |
